/People

Sven Kili

Investor

Partner at Saisei Ventures

United Kingdom

Find your path to Sven

442 people in our graph can introduce you to Sven.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Ryosuke Yao to introduce you to Sven

You →Ryosuke · together at Saisei Ventures (2024–2026) →Sven

Ask Jamie Chen to introduce you to Sven

You →Jamie · 3 people · together at Saisei Ventures →Sven

Ask Sam Okafor to introduce you to Sven

You →Sam · 2 people · together at BioIndustry Association →Sven

Sign up to find every way you can get introduced to Sven

  • Your email: the people you already email who know Sven
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Sven
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Sven Kili is a Partner at Saisei Ventures and a pharmaceutical physician with clinical experience in surgical and medical disciplines. He serves as a Translational Research grant committee member at the British Heart Foundation, a Board Member and Interim CMO and COO at Xintela AB, a Board Member and Investment Committee member at CCRM, Chair of the BIA Cell & Gene Advisory Committee, and an Executive Board Member of the Standards Coordinating Body. His areas of work include cell and gene therapies, clinical development, medical affairs, regulatory strategy for medicines and ATMP products, and market access planning.

Contact· self-published, not guessed

Experience

  1. British Heart FoundationTranslational Research grant committee membercurrent2025 — present
  2. Saisei VenturesPartnercurrent2025 — present
  3. Saisei VenturesInvestment Advisor2023 — 2025
  4. Innovation Hubs for Gene TherapiesSteering Committee Chairmancurrent2021 — present
  5. SVEN KILI CONSULTING LTDPrincipalcurrent2018 — present
  6. UCLSteering Committee Chaircurrent2019 — presentLondon Area, United Kingdom
  7. BioIndustry AssociationChair - Cell & Gene Therapy Advisory Committeecurrent2016 — presentLondon Area, United Kingdom
  8. CCRMChief Development Officer2024 — 2025
  9. CCRMMember of the Board2017 — 2024Greater Toronto Area, Canada
  10. LGC GroupMember of The Scientific Advisory Board2019 — 2025London Area, United Kingdom
  11. Antion Biosciences SAChief Executive Officer2020 — 2023
  12. Xintela ABMember of the Board2014 — 2022Kalmar County, Sweden
  13. Standards Coordinating Body (SCB)Member of Executive Board2016 — 2020Washington DC-Baltimore Area
  14. GSKVP and Head of Cell & Gene Therapy Development2015 — 2018London Area, United Kingdom
  15. Genzyme BiosurgerySenior Director, Global Medical Affairs - Cell Therapy & Regenerative Medicine2011 — 2015UK & Boston
  16. Genzyme TherapeuticsSenior Associate Medical Director - Renal, CV and Biosurgery2011
  17. Genzyme BiosurgeryMedical Director - MACI2009 — 2010
  18. Genzyme BiosurgeryAssociate Medical Director2008 — 2009
  19. Geistlich BiomaterialsSenior Medical Advisor2004 — 2008
  20. NHSTrauma & Orthopaedics Specialist Registrar2000 — 2004
  21. NHSBasic Surgical Trainee1997 — 1999
  22. Don Fosters Dive, CaymanDive Instructor & Boat Captain1987 — 1989
  23. South African Defense ForceSignals and Encryption Officer1985 — 1986

Skills & more

Strategic Planning2Operational Execution1Due DiligenceInvestments1Clinical Research63Surgery15Pharmaceuticals2Biotechnology45Medical Devices43Clinical Trials74Regulatory Affairs4Pharmacovigilance28
+10 moreOrthopedicMedical AffairsUrologyHospitalsMedicineHealthcareClinical DevelopmentRegulatory SubmissionsFDAClinical

From Sven's professional profile.

Colleagues at Saisei Ventures

Frequently asked questions

Who is Sven Kili?
Sven Kili is a Partner at Saisei Ventures and a pharmaceutical physician with clinical experience in surgical and medical disciplines. He serves as a Translational Research grant committee member at the British Heart Foundation, a Board Member and Interim CMO and COO at Xintela AB, a Board Member and Investment Committee member at CCRM, Chair of the BIA Cell & Gene Advisory Committee, and an Executive Board Member of the Standards Coordinating Body. His areas of work include cell and gene therapies, clinical development, medical affairs, regulatory strategy for medicines and ATMP products, and market access planning.
Where does Sven Kili work?
Sven Kili is Partner at Saisei Ventures.
Where did Sven Kili go to school?
Sven Kili studied at Royal College of Surgeons of England (MRCS, Surgery); Stellenbosch University (MB ChB, Medicine & Surgery).

Same school

Shared employers